Medicines in Development for Biologics 2013 Report

PhRMA April 8, 2013

America’s biopharmaceutical research companies are developing 907 biologics targeting more than 100 diseases. Biologics are developed through biological processes using living cells or organisms. This report lists biologics in human clinical trials or under review by the U.S. Food and Drug Administration (FDA). A link to the sponsor company’s web site provides more detailed information on the science and technologies behind each potential product. There are 907 medicines and vaccines in development for biologics.